Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Rheumatoid arthritis: RA--lowering cardiovascular risk with statins.

× No keyword cloud information.

9 in total

1. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.

Authors: P M Ridker; C H Hennekens; J E Buring; N Rifai
Journal: N Engl J Med Date: 2000-03-23 Impact factor: 91.245

Review 2. Vascular effects of biologic agents in RA and spondyloarthropathies.

Authors: Zoltán Szekanecz; György Kerekes; Pál Soltész
Journal: Nat Rev Rheumatol Date: 2009-11-10 Impact factor: 20.543

3. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

Authors: Paul M Ridker; Eleanor Danielson; Francisco A H Fonseca; Jacques Genest; Antonio M Gotto; John J P Kastelein; Wolfgang Koenig; Peter Libby; Alberto J Lorenzatti; Jean G MacFadyen; Børge G Nordestgaard; James Shepherd; James T Willerson; Robert J Glynn
Journal: N Engl J Med Date: 2008-11-09 Impact factor: 91.245

4. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.

Authors: Helen M Colhoun; D John Betteridge; Paul N Durrington; Graham A Hitman; H Andrew W Neil; Shona J Livingstone; Margaret J Thomason; Michael I Mackness; Valentine Charlton-Menys; John H Fuller
Journal: Lancet Date: 2004 Aug 21-27 Impact factor: 79.321

5. Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial.

Authors: David W McCarey; Iain B McInnes; Rajan Madhok; Rosie Hampson; Olga Scherbakov; Ian Ford; Hilary A Capell; Naveed Sattar
Journal: Lancet Date: 2004-06-19 Impact factor: 79.321

6. Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk?

Authors: Tracey E Toms; Vasileios F Panoulas; Karen M J Douglas; Helen Griffiths; Naveed Sattar; Jaqueline P Smith; Deborah P M Symmons; Peter Nightingale; George S Metsios; George D Kitas
Journal: Ann Rheum Dis Date: 2009-10-23 Impact factor: 19.103

7. Effects of high-dose atorvastatin on antiinflammatory properties of high density lipoprotein in patients with rheumatoid arthritis: a pilot study.

Authors: Christina Charles-Schoeman; Dinesh Khanna; Daniel E Furst; Maureen McMahon; Srinivasa T Reddy; Alan M Fogelman; Harold E Paulus; Grace S Park; Timothy Gong; Benjamin J Ansell
Journal: J Rheumatol Date: 2007-06-01 Impact factor: 4.666

Review 8. Molecular imaging in atherosclerosis, thrombosis, and vascular inflammation.

Authors: Robin P Choudhury; Edward A Fisher
Journal: Arterioscler Thromb Vasc Biol Date: 2009-02-12 Impact factor: 8.311

9. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

Authors:
Journal: Lancet Date: 2002-07-06 Impact factor: 79.321

9 in total